IADR Abstract Archives

Dentifrice Protection Against Dentin Demineralization in an In Vitro Study

OBJECTIVE: When applied directly to the tooth surface or incorporated into a dentifrice, NovaMin® relieves hypersensitivity by occluding dentinal tubules through the formation of an acid-resistant apatite layer. This work evaluates the ability of two calcium phosphate-containing materials to protect dentin from demineralization during a 10-day in vitro remineralization/demineralization (remin/demin) study.

METHODS: Bovine tooth roots were ground, polished, and acid-etched to expose the dentin layer and create an in vitro hypersensitivity model. Randomly-selected samples were left untreated and represent “sound” dentin. The remaining samples were subjected to a 10-day remin/demin cycle that consisted of a twice-daily 30-minute soak in demineralizing solution (pH=4.52) at 37°C followed by a two-minute brushing with either NovaMin®-containing SootheRx™, RECALDENT™-containing MI Paste, or DI water. Samples were soaked in artificial saliva (pH=7.00) at 37°C between the two daily demineralization/brushing periods. Samples treated with only DI water are referred to as “demineralized” dentin. Knoop hardness (KH) was measured on all dentin surfaces using a load of 50 grams for 15 seconds. Results were analyzed using ANOVA and Holm-Sidak tests (p<0.01).

RESULTS: All data are mean±S.E.M. with n=15. Demineralized dentin had a KH (50.85±0.85) that was significantly lower than sound dentin (65.43±0.50, p<0.001). The KH of dentin treated with NovaMin® during the remin/demin cycle (79.75±1.10, p<0.001) was significantly greater than sound and demineralized dentin. Dentin treated with RECALDENT™ had a KH (52.12±1.27) that was significantly lower than sound dentin (p<0.001) and did not differ from demineralized dentin (p=0.358).

CONCLUSION: Current microhardness data indicate that treatment with a NovaMin®-containing dentifrice creates a tenacious surface layer that protects dentin from demineralization caused by repeated acid challenges. Within the limitations of this model, however, the same protection was not provided by amorphous RECALDENT™. These results further explain the observed reductions in clinical hypersensitivity following treatment with a NovaMin®-containing dentifrice.


Division: IADR/AADR/CADR General Session
Meeting: 2007 IADR/AADR/CADR General Session (New Orleans, Louisiana)
Location: New Orleans, Louisiana
Year: 2007
Final Presentation ID: 1764
Abstract Category|Abstract Category(s): Mineralized Tissue
Authors
  • Burwell, Anora Kirsten  ( NovaMin Technology, Inc, Alachua, FL, USA )
  • Greenspan, David C.  ( NovaMin Technology, Inc, Alachua, FL, USA )
  • SESSION INFORMATION
    Poster Session
    Therapeutics
    03/23/2007